Lott IT - Search Results

1

The Alzheimer's Biomarker Consortium-Down Syndrome: Rationale and methodology.

Handen BL, Lott IT, Christian BT, Schupf N, OBryant S, Mapstone M, Fagan AM, Lee JH, Tudorascu D, Wang MC, Head E, Klunk W, Ances B, Lai F, Zaman S, Krinsky-McHale S, Brickman AM, Rosas HD, Cohen A, Andrews H, Hartley S, Silverman W; Alzheimer's Biomarker Consortium‐Down Syndrome (ABC‐DS). Handen BL, et al. Among authors: lott it. Alzheimers Dement (Amst). 2020 Aug 3;12(1):e12065. doi: 10.1002/dad2.12065. eCollection 2020. Alzheimers Dement (Amst). 2020. PMID: 32775597 Free PMC article. Review.

2

Down syndrome and beta-amyloid deposition.

Head E, Lott IT. Head E, et al. Among authors: lott it. Curr Opin Neurol. 2004 Apr;17(2):95-100. doi: 10.1097/00019052-200404000-00003. Curr Opin Neurol. 2004. PMID: 15021233 Review.

3

Alzheimer disease and Down syndrome: factors in pathogenesis.

Lott IT, Head E. Lott IT, et al. Neurobiol Aging. 2005 Mar;26(3):383-9. doi: 10.1016/j.neurobiolaging.2004.08.005. Neurobiol Aging. 2005. PMID: 15639317 Review.

4

Beta-amyloid, oxidative stress and down syndrome.

Lott IT, Head E, Doran E, Busciglio J. Lott IT, et al. Curr Alzheimer Res. 2006 Dec;3(5):521-8. doi: 10.2174/156720506779025305. Curr Alzheimer Res. 2006. PMID: 17168651 Review.

5

Telemedicine, dementia and Down syndrome: implications for Alzheimer disease.

Lott IT, Doran E, Walsh DM, Hill MA. Lott IT, et al. Alzheimers Dement. 2006 Jul;2(3):179-84. doi: 10.1016/j.jalz.2006.04.001. Alzheimers Dement. 2006. PMID: 19595881

6

Systemic mitochondrial dysfunction and the etiology of Alzheimer's disease and down syndrome dementia.

Coskun PE, Wyrembak J, Derbereva O, Melkonian G, Doran E, Lott IT, Head E, Cotman CW, Wallace DC. Coskun PE, et al. Among authors: lott it. J Alzheimers Dis. 2010;20 Suppl 2(0 2):S293-310. doi: 10.3233/JAD-2010-100351. J Alzheimers Dis. 2010. PMID: 20463402 Free PMC article.

7

Plasma amyloid-β as a function of age, level of intellectual disability, and presence of dementia in Down syndrome.

Head E, Doran E, Nistor M, Hill M, Schmitt FA, Haier RJ, Lott IT. Head E, et al. Among authors: lott it. J Alzheimers Dis. 2011;23(3):399-409. doi: 10.3233/JAD-2010-101335. J Alzheimers Dis. 2011. PMID: 21116050 Free PMC article.

8

Down syndrome and dementia: a randomized, controlled trial of antioxidant supplementation.

Lott IT, Doran E, Nguyen VQ, Tournay A, Head E, Gillen DL. Lott IT, et al. Am J Med Genet A. 2011 Aug;155A(8):1939-48. doi: 10.1002/ajmg.a.34114. Epub 2011 Jul 7. Am J Med Genet A. 2011. PMID: 21739598 Free PMC article. Clinical Trial.

9

Association between frontal cortex oxidative damage and beta-amyloid as a function of age in Down syndrome.

Cenini G, Dowling AL, Beckett TL, Barone E, Mancuso C, Murphy MP, Levine H 3rd, Lott IT, Schmitt FA, Butterfield DA, Head E. Cenini G, et al. Among authors: lott it. Biochim Biophys Acta. 2012 Feb;1822(2):130-8. doi: 10.1016/j.bbadis.2011.10.001. Epub 2011 Oct 8. Biochim Biophys Acta. 2012. PMID: 22009041 Free PMC article.

10

Aging and down syndrome.

Head E, Silverman W, Patterson D, Lott IT. Head E, et al. Among authors: lott it. Curr Gerontol Geriatr Res. 2012;2012:412536. doi: 10.1155/2012/412536. Epub 2012 Jul 11. Curr Gerontol Geriatr Res. 2012. PMID: 22844278 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

128 results

Search Page